Becker's Healthcare October 23, 2024
Alexandra Murphy

In 2023, the top 10 drugs purchased under the 340B Drug Pricing Program accounted for roughly one-third of the program’s total spending, according to a Health Resources and Services Administration news release.

Here is a breakdown of the 10 priciest 340B medications:

  1. Keytruda (oncology): $6.91 billion in sales...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, Pharma, Pharma / Biotech, Provider
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article